Fate of Various Dendrimers with Different Sizes and Surfaces after Subcutaneous and Intradermal Administration
Chie Kojima
Osaka Prefecture University
Dr. Kojima entered Department of Applied Materials Science, College of Engineering, Osaka Prefecture University (OPU) in Japan, and skipped her 4th grade of her undergraduate course. She received her master's degree in Engineering from OPU in 2001. She received her Ph.D. in Biostudies from Kyoto University in 2005. She was an assistant professor in OPU from 2005 to 2008. In 2008, she was a visiting scientist of National Cancer Institute/ National Institute of Health in USA. She was a tenure-track lecturer in OPU from 2009 to 2013. She passed the tenure screening and got her present position in 2014.
Abstract
Dendrimers are synthetic macromolecules with highly controllable structures, which are potent multifunctional nanoparticles for drug delivery system and imaging. There are many reports on intravenous administration of... [ view full abstract ]
Dendrimers are synthetic macromolecules with highly controllable structures, which are potent multifunctional nanoparticles for drug delivery system and imaging. There are many reports on intravenous administration of dendrimer, but few on intradermal and subcutaneous administration. In this study, various dendrimers of different generations (G2, G4, G6, and G8) and different surfaces (amino, carboxyl, acetyl and collagen peptide modification) were prepared and radiolabeled. First, the radiolabeled dendrimers were intradermally administrated to the right footpad of rats. All G2 dendrimers were predominantly accumulated in the kidney. Amino-terminal, acetyl-terminal and carboxy-terminal dendrimers of greater than G4 were mostly located at the injection site, in blood and in the popliteal lymph node, respectively. Interestingly, the carboxy-terminal dendrimers were not largely recognized by macrophages and T cells in the lymph node. Finally, the lymph detection was performed by single photon emission computed tomography (SPECT) imaging using various dendrimers. (Figure 1). Carboxy-terminal dendrimers of greater than G4 and amino-terminal G6 dendrimer (G6-NH2) successfully visualized the popliteal lymph node (indicated by arrows), but acetyl-terminal G6 dendrimer (G6-Ac) and carboxy-terminal G2 dendrimer (G2-COOH) did not. Compared with the COOH-terminal dendrimers of higher than G4, G6-NH2 was largely retained at the injection site (indicated by arrow heads). These results suggest that carboxy-terminal dendrimers of greater than G4 are useful for drug delivery and imaging of sentinel lymph node, which the first lymph node draining tumor cells. Next, the radiolabeled dendrimers were subcutaneously administrated into tumor-bearing mice, and monitored by using SPECT imaging. Acetylated G4 dendrimer (Ac-G4) and collagen peptide-conjugated dendrimer (CP-G4) were largely retained at the injection site for at least 1 day (indicated by arrows). Ac-G4 were partly accumulated in the kidney (indicated by K), but the CP-G4 was not (Figure 2). On the other hand, these dendrimers were accumulated in the liver and the kidney following intravenous administration. These results indicate that the subcutaneously injected dendrimers did not largely gain substantial access to the systemic circulation, which is useful for a depot of drug around the injection site.
Authors
-
Chie Kojima
(Osaka Prefecture University)
Topic Areas
Nanomedecine for cancer diagnosis & therapy , Nano-Imaging for diagnosis, therapy and delivery
Session
OS2-103 » Nanomedecine for cancer diagnosis & therapy (16:00 - Thursday, 29th September, Tower 24 - Room 103)
Presentation Files
The presenter has not uploaded any presentation files.